Skip to content

Other product segments

Health
83%+0.2%
Multiline
73%-1.9%
Financial
51.6%-23.2%
Casualty
34%+0.6%
Property
33.5%+0.9%

Similar metrics at other companies

Arch Capital Group logo
ACGLSpecialty — Year Two
28.2%-1.0pp
Horace Mann Educators logo
HMNSpecialty Health — Year Two
35.1%+6.6pp
SiriusPoint logo
SPNTOther Specialties — Year 2
44.2%-0.3pp
White Mountains Insurance Group logo
WTMSpecialty — 2
26.8%-4.0pp
SiriusPoint logo
SPNTOther Specialties — Year 1
43.9%+2.6pp
Skyward Specialty Insurance Group, Inc. logo
SKWDShort-tail/Monoline Specialty Lines — Year 2
38.1%+0.4pp

Other financials

Income statement

See full
Revenue$189.7M-11.1%
Net income$35.8M+20.7%
EPS (diluted)$1.05+22.1%

Balance sheet

See full
Cash & equivalents$610.2M-5.1%
Total debt$4.7M-92.1%
Total equity$741.2M+11.2%
Total assets$2.3B+5.4%

Cash flow

See full
Operating cash flow$37.2M+259%

Valuation

See full
Market cap$533.32M+7.2%
Enterprise value-$72.18M-15.4%
P/E6.6×
P/S0.8×+0.1×

Profitability

See full
Net margin11.5%
FCF margin-46.7%

Returns & leverage

See full
Return on equity11.5%
Debt / equity-0.1×

Where this comes from

Reported directly by Greenlight Capital RE, Ltd. in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo.

The official record: Greenlight Capital RE, Ltd.’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Greenlight Capital RE, Ltd.'s specialty — year 2.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Greenlight Capital RE, Ltd.'s specialty — year 2?
Greenlight Capital RE, Ltd. (GLRE) reported specialty — year 2 of 45% in Q4 2025.
What does specialty — year 2 mean?
This metric tracks the specialty segment's underwriting performance or claims development during the second year following the initial policy cohort. It helps in assessing the maturation of specialty claims and the accuracy of initial loss estimates. Consistent performance across years indicates stable underwriting discipline in the specialty segment.